Roxana Mehran, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Janssen Scientific Affairs(MODEST), Cine-Med Research Institute(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Applied Therapeutics(SIGNIFICANT), STEL(SIGNIFICANT), CONTROLRAD(SIGNIFICANT), Boston Scientific(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), CSL Behring (SIGNIFICANT), DSI(SIGNIFICANT), Medtronic(SIGNIFICANT), OrbusNeich(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Concept Medical(SIGNIFICANT), Chiesi(SIGNIFICANT), CERC(SIGNIFICANT), Abiomed(SIGNIFICANT), CardiaWave(SIGNIFICANT), Biosensors(SIGNIFICANT), Arena(SIGNIFICANT), Boston Scientific(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Elixir Medical(MODEST), WebMD(SIGNIFICANT)

View Full Disclosure